{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:07:17Z","timestamp":1784045237507,"version":"3.55.0"},"reference-count":134,"publisher":"Elsevier","isbn-type":[{"value":"9780443345234","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apcsb.2026.04.005","type":"book-chapter","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:28:39Z","timestamp":1782559719000},"page":"1-57","source":"Crossref","is-referenced-by-count":0,"title":["Recent strategies and approaches for the development of molecularly targeted nanomedicine"],"prefix":"10.1016","author":[{"given":"Aman","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Hidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balak","family":"Das Kurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13041-022-00937-4","article-title":"Blood\u2013brain barrier: Emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders","volume":"15","author":"Alajangi","year":"2022","journal-title":"Molecular Brain"},{"issue":"12","key":"10.1016\/bs.apcsb.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/pharmaceutics17121602","article-title":"Advances in mesoporous silica and hybrid nanoparticles for drug delivery: Synthesis, Functionalization, and biomedical applications","volume":"17","author":"Almatroudi","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.04.005_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11051-024-05983-8","article-title":"Advancements in neurotherapeutics: Nanoparticles overcoming the blood\u2013brain barrier for precise CNS targeting","volume":"26","author":"Alqudah","year":"2024","journal-title":"Journal of Nanoparticle Research"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.103085","article-title":"A judicious review on the applications of chemotherapeutic loaded nanoemulsions in cancer management","volume":"68","author":"Alshahrani","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"4","key":"10.1016\/bs.apcsb.2026.04.005_bib5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes & Diseases"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104432","article-title":"Nanomaterials as an advanced nano-tool for the doxorubicin delivery\/ co-delivery\u2014A comprehensive review","volume":"83","author":"Arshad","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"8","key":"10.1016\/bs.apcsb.2026.04.005_bib7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"10","key":"10.1016\/bs.apcsb.2026.04.005_bib8","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s13346-021-01103-4","article-title":"Critical parameters for design and development of multivalent nanoconstructs: Recent trends","volume":"12","author":"Bakshi","year":"2022","journal-title":"Drug Delivery and Translational Research"},{"issue":"12","key":"10.1016\/bs.apcsb.2026.04.005_bib9","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s00210-023-02612-4","article-title":"Ligand-based active targeting strategies for cancer theranostics","volume":"396","author":"Bandyopadhyay","year":"2023","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib10","first-page":"1","article-title":"Machine learning prediction of protein adsorption on drug-delivering nanoparticles: A literature survey and need for future development","author":"Basu","year":"2025","journal-title":"Pharmaceutical Research"},{"issue":"9","key":"10.1016\/bs.apcsb.2026.04.005_bib11","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chemical Reviews"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib12","series-title":"Nanotheranostics and precision oncology","first-page":"339","article-title":"Active and passive targeting of nanoparticles","author":"Butt","year":"2026"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117704","article-title":"Advanced biological optical sensors for visualization and quantification of radionuclides","volume":"175","author":"Cai","year":"2024","journal-title":"TrAC Trends in Analytical Chemistry"},{"issue":"23","key":"10.1016\/bs.apcsb.2026.04.005_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300474","article-title":"Bioorthogonal chemistry in translational research: Advances and opportunities","volume":"24","author":"Chaudhuri","year":"2023","journal-title":"Chembiochem: a European Journal of Chemical Biology"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-981-96-3456-9_10","article-title":"Challenges and opportunities used in RNA-based therapeutics","author":"Chauhan","year":"2025","journal-title":"RNA-Based Cancer Therapeutics: Techniques, Applications and Challenges in Prognosis"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: Overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Molecular Cancer"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1049\/bsb2.12029","article-title":"The structure, formation, and effect of plasma protein layer on the blood contact materials: A review","volume":"8","author":"Chen","year":"2022","journal-title":"Biosurface and Biotribology"},{"issue":"11","key":"10.1016\/bs.apcsb.2026.04.005_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1080\/17425247.2022.2134853","article-title":"Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms","volume":"19","author":"Chen","year":"2022","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12951-024-02892-9","article-title":"Nanocarriers for targeted drug delivery in the vascular system: Focus on endothelium","volume":"22","author":"Cong","year":"2024","journal-title":"Journal of Nanobiotechnology"},{"issue":"36","key":"10.1016\/bs.apcsb.2026.04.005_bib20","doi-asserted-by":"crossref","first-page":"50142","DOI":"10.1021\/acsami.5c10918","article-title":"Designing protein-based nanoparticles for therapeutic applications","volume":"17","author":"Cui","year":"2025","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib21","article-title":"Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges [Systematic Review]","volume":"4","author":"Das","year":"2022","journal-title":"Frontiers in Medical Technology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12951-022-01595-3","article-title":"Emerging trends in the nanomedicine applications of functionalized magnetic nanoparticles as novel therapies for acute and chronic diseases","volume":"20","author":"Dash","year":"2022","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.115189","article-title":"CD44-targeted NLCs improve trans-resveratrol in vitro cellular uptake and cytotoxicity in high-grade glioma cells","volume":"257","author":"de Almeida","year":"2026","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"10","key":"10.1016\/bs.apcsb.2026.04.005_bib24","article-title":"Structure-based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles","volume":"9","author":"De","year":"2022","journal-title":"Advanced Science\u00a0(Weinh)"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib25","series-title":"A comprehensive guide to toxicology in nonclinical drug development","first-page":"149","article-title":"Acute, subacute, subchronic, and chronic general toxicity testing for preclinical drug development","author":"Denny","year":"2024"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nxnano.2025.100286","article-title":"Next-gen cancer therapy: The convergence of artificial intelligence, nanotechnology, and digital twin","volume":"8","author":"Deshmukh","year":"2025","journal-title":"Next Nanotechnology"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.04.005_bib27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/0126673878301004240703073107","article-title":"Functionalised ligand-based nanomaterial drug targeting approaches for colorectal cancer therapy","volume":"18","author":"Dixit","year":"2024","journal-title":"Recent Advances in Drug Delivery and Formulation"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2023.01.022","article-title":"\u201cHook&Loop\u201d multivalent interactions based on disk-shaped nanoparticles strengthen active targeting","volume":"354","author":"Dong","year":"2023","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.04.005_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib30","first-page":"353","article-title":"Role of nanotechnology in medicine: Opportunities and challenges","author":"Ejidike","year":"2024","journal-title":"Biogenic Nanomaterials for Environmental Sustainability: Principles, Practices, and Opportunities"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114205","article-title":"Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis","volume":"196","author":"El-Dakroury","year":"2024","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41120-023-00080-x","article-title":"A review on lipid-based nanocarriers mimicking chylomicron and their potential in drug delivery and targeting infectious and cancerous diseases","volume":"9","author":"Elnady","year":"2023","journal-title":"AAPS Open"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121001","article-title":"Efficient lung-targeted delivery of risedronate sodium\/vitamin D3 conjugated PAMAM-G5 dendrimers for managing osteoporosis: Pharmacodynamics, molecular pathways and metabolomics considerations","volume":"309","author":"Elsayyad","year":"2022","journal-title":"Life Sciences"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.04.005_bib34","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1039\/D5RA07117H","article-title":"Self-assembling nanocomposites for smart drug delivery: Towards personalized and stimuli-responsive therapeutics","volume":"16","author":"Emadi","year":"2026","journal-title":"RSC Advances"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.04.005_bib35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.34172\/apb.2024.046","article-title":"Targeted hybrid nanocarriers as co-delivery systems for enhanced cancer therapy","volume":"14","author":"Erebor","year":"2024","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.04.005_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in drug delivery systems, challenges and future directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduction Targeted Therapies"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"4","key":"10.1016\/bs.apcsb.2026.04.005_bib39","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1002\/j.2040-4603.2022.tb00232.x","article-title":"Endothelial glycocalyx","volume":"12","author":"Foote","year":"2022","journal-title":"Comprehensive Physiology"},{"issue":"25","key":"10.1016\/bs.apcsb.2026.04.005_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300319","article-title":"A comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles","volume":"12","author":"Gandek","year":"2023","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib41","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.2147\/IJN.S549893","article-title":"Nanotechnology for neurodegenerative diseases: Recent progress in brain-targeted delivery, stimuli-responsive platforms, and organelle-specific therapeutics","author":"Gao","year":"2025","journal-title":"International Journal of Nanomedicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43094-022-00414-8","article-title":"Nanostructured lipid carriers: A Promising drug carrier for targeting brain tumours","volume":"8","author":"Garg","year":"2022","journal-title":"Future Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib43","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.2147\/DDDT.S481420","article-title":"Optimizing pharmacological and immunological properties of therapeutic proteins through PEGylation: Investigating key parameters and their impact","author":"Gon\u00e7alves","year":"2024","journal-title":"Drug Design, Development and Therapy"},{"issue":"11","key":"10.1016\/bs.apcsb.2026.04.005_bib44","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1007\/s13346-023-01366-z","article-title":"Lipid-based nanoparticle-mediated combination therapy for breast cancer management: a comprehensive review","volume":"13","author":"Gupta","year":"2023","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib45","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.2147\/IJN.S386037","article-title":"Insights on the dynamic innovative tumor targeted-nanoparticles-based drug delivery systems activation techniques","volume":"17","author":"Hamdy","year":"2022","journal-title":"International Journal of Nanomedicine"},{"issue":"10","key":"10.1016\/bs.apcsb.2026.04.005_bib46","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/1061186X.2024.2393417","article-title":"Artificial intelligence in nanotechnology for treatment of diseases","volume":"32","author":"Heydari","year":"2024","journal-title":"Journal of Drug Targeting"},{"issue":"12","key":"10.1016\/bs.apcsb.2026.04.005_bib47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nature Reviews Materials"},{"issue":"7","key":"10.1016\/bs.apcsb.2026.04.005_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071821","article-title":"Biomimetic cell-derived nanoparticles: Emerging platforms for cancer immunotherapy","volume":"15","author":"Hu","year":"2023","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/bs.apcsb.2026.04.005_bib49","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/elsc.201800038","article-title":"Silica-based organic-inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery","volume":"18","author":"Ilhan-Ayisigi","year":"2018","journal-title":"Engineering in Life Sciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1039\/D2LC00611A","article-title":"Capturing the spatial and temporal dynamics of tumor stroma for on-chip optimization of microenvironmental targeting nanomedicine","volume":"23","author":"Imparato","year":"2023","journal-title":"Lab on a Chip"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.rsurfi.2025.100529","article-title":"Advances in nanoparticles in targeted drug delivery\u2013A review","volume":"19","author":"Islam","year":"2025","journal-title":"Results in Surfaces and Interfaces"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s44174-024-00179-z","article-title":"Biomimetic nanoparticles for cancer therapy: A review of recent advances, applications, and bottlenecks","volume":"3","author":"Issaka","year":"2025","journal-title":"Biomedical Materials & Devices"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib53","first-page":"1","article-title":"Nanotechnology-based PD-L1 siRNA codelivery systems for improving cancer immunotherapy","author":"Jabarimani","year":"2025","journal-title":"Journal of Drug Targeting(just-accepted)"},{"issue":"11","key":"10.1016\/bs.apcsb.2026.04.005_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.70017","article-title":"Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics","volume":"3","author":"Jackson Cullison","year":"2024","journal-title":"Journal of Extracellular Biology"},{"issue":"12","key":"10.1016\/bs.apcsb.2026.04.005_bib55","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/ph18121772","article-title":"Advances in lipid-polymer hybrid nanoparticles: Design strategies, functionalization, oncological and non-oncological clinical prospects","volume":"18","author":"Jacob","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"10.1016\/bs.apcsb.2026.04.005_bib56","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41551-025-01385-w","article-title":"Enhanced nanoparticle delivery across vascular basement membranes of tumours using nitric oxide","volume":"9","author":"Jiang","year":"2025","journal-title":"Nature Biomedical Engineering"},{"issue":"8","key":"10.1016\/bs.apcsb.2026.04.005_bib57","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1007\/s11831-023-09948-3","article-title":"Amalgamation of artificial intelligence with nanoscience for biomedical applications","volume":"30","author":"Kasture","year":"2023","journal-title":"Archives of Computational Methods in Engineering"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12943-023-01798-8","article-title":"Gold nanoparticles and gold nanorods in the landscape of cancer therapy","volume":"22","author":"Kesharwani","year":"2023","journal-title":"Molecular Cancer"},{"issue":"9","key":"10.1016\/bs.apcsb.2026.04.005_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202300047","article-title":"Structurally engineered silica shells on gold nanorods for biomedical applications","volume":"4","author":"Kim","year":"2023","journal-title":"Small Structures"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.624082","article-title":"Glycans and glycan-binding proteins as regulators and potential targets in leukocyte recruitment","volume":"9","author":"Krautter","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"11","key":"10.1016\/bs.apcsb.2026.04.005_bib61","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/bit.28205","article-title":"Ligand conjugated lipid\u2010based nanocarriers for cancer theranostics","volume":"119","author":"Kumar","year":"2022","journal-title":"Biotechnology and Bioengineering"},{"issue":"11","key":"10.1016\/bs.apcsb.2026.04.005_bib62","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1021\/cbe.5c00048","article-title":"Recent advances in machine learning models for predicting toxicity of inorganic nanoparticles","volume":"2","author":"Li","year":"2025","journal-title":"Chem & Bio Engineering"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib63","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1038\/s41467-024-52416-0","article-title":"Transvascular transport of nanocarriers for tumor delivery","volume":"15","author":"Li","year":"2024","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","article-title":"Multifunctional nanoparticle-mediated combining therapy for human diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduction Targeted Therapies"},{"issue":"2","key":"10.1016\/bs.apcsb.2026.04.005_bib65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/1061186X.2023.2300694","article-title":"Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy","volume":"32","author":"Li","year":"2024","journal-title":"Journal of Drug Targeting"},{"issue":"22","key":"10.1016\/bs.apcsb.2026.04.005_bib66","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Advanced Science\u00a0(Weinh)"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib67","first-page":"1","article-title":"Radionuclide-based nanotechnologies in brain tumors: an updated overview","author":"Librando","year":"2025","journal-title":"Clinical and Translational Imaging"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2025.10.026","article-title":"Progress in peptide and protein therapeutics: Challenges and strategies","author":"Liu","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib69","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.addr.2021.01.008","article-title":"Harnessing molecular recognition for localized drug delivery","volume":"170","author":"Liu","year":"2021","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2025.102223","article-title":"Mesoporous silica nanoparticle-based nanomedicine: Preparation, functional modification, and theranostic applications","volume":"34","author":"Liu","year":"2025","journal-title":"Materials Today Bio"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib71","article-title":"Nucleic acid nanotechnology in tumor microenvironment research: From illumination to intervention for enhanced immunotherapy","author":"Lu","year":"2026","journal-title":"Chemical Society Reviews"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2024.1456939","article-title":"Recent advances in surface decoration of nanoparticles in drug delivery","volume":"6","author":"Ly","year":"2024","journal-title":"Frontiers in Nanotechnology"},{"issue":"2","key":"10.1016\/bs.apcsb.2026.04.005_bib73","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/cbdd.14230","article-title":"Perspectives on cutting\u2010edge nanoparticulate drug delivery technologies based on lipids and their applications","volume":"102","author":"Maddiboyina","year":"2023","journal-title":"Chemical Biology & Drug Design"},{"issue":"8","key":"10.1016\/bs.apcsb.2026.04.005_bib74","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1021\/acs.molpharmaceut.5c00056","article-title":"Roadmap for commercial nanomedicine development: Integrating quality by design principles with pharmaceutical nanotechnology","volume":"22","author":"Maheshwari","year":"2025","journal-title":"Molecular Pharmaceutics"},{"issue":"15","key":"10.1016\/bs.apcsb.2026.04.005_bib75","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1080\/17435889.2025.2533107","article-title":"Regulating nanomedicines: Challenges, opportunities, and the path forward","volume":"20","author":"Mangla","year":"2025","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"8","key":"10.1016\/bs.apcsb.2026.04.005_bib76","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/pharmaceutics17081082","article-title":"Stimuli-responsive, cell-mediated drug delivery systems: Engineering smart cellular vehicles for precision therapeutics","volume":"17","author":"Mashele","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00253-021-11713-0","article-title":"Current view on novel vaccine technologies to combat human infectious diseases","volume":"106","author":"Mati\u0107","year":"2022","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17425247.2024.2440618","article-title":"Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes","volume":"22","author":"Mazumdar","year":"2025","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.04.005_bib79","doi-asserted-by":"crossref","first-page":"512","DOI":"10.34172\/apb.2023.062","article-title":"Drug delivery of solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) to target brain tumors","volume":"13","author":"Mehrdadi","year":"2022","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"8","key":"10.1016\/bs.apcsb.2026.04.005_bib80","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/cbf.3880","article-title":"Evasion of opsonization of macromolecules using novel surface\u2010modification and biological\u2010camouflage\u2010mediated techniques for next\u2010generation drug delivery","volume":"41","author":"Mehta","year":"2023","journal-title":"Cell Biochemistry and Function"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jece.2025.120981","article-title":"Functional polymer micelles based on quaternized polyethyleneimine for efficient delivery of insoluble fungicide with synergistic antimicrobial activity","volume":"14","author":"Meng","year":"2026","journal-title":"Journal of Environmental Chemical Engineering"},{"issue":"12","key":"10.1016\/bs.apcsb.2026.04.005_bib82","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1039\/D2BM00181K","article-title":"Nanoparticle based medicines: Approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation","volume":"10","author":"Mills","year":"2022","journal-title":"Biomaterials Science"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.04.005_bib83","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/pharmaceutics17060682","article-title":"Synergistic cancer therapies enhanced by nanoparticles: Advancing nanomedicine through multimodal strategies","volume":"17","author":"Mousavi-Kiasary","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib84","doi-asserted-by":"crossref","DOI":"10.4161\/mabs.2.1.10786","article-title":"Antibody fragments: Hope and hype","author":"Nelson","year":"2010","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pharmtox-010716-104558","article-title":"Aptamers as therapeutics","volume":"57","author":"Nimjee","year":"2017","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100083","article-title":"Overcoming challenges to enable targeting of metastatic breast cancer tumour microenvironment with nano-therapeutics: Current status and future perspectives","volume":"8","author":"Niveria","year":"2022","journal-title":"OpenNano"},{"issue":"5","key":"10.1016\/bs.apcsb.2026.04.005_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: Structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"51","key":"10.1016\/bs.apcsb.2026.04.005_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202304514","article-title":"Manganese\u2010based nanoparticle vaccine for combating fatal bacterial pneumonia","volume":"35","author":"OuYang","year":"2023","journal-title":"Advanced Materials"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib89","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief update on endocytosis of nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103836","article-title":"Tumor\u2010microenvironment\u2010responsive nanomedicine for enhanced cancer immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Advanced Science"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib91","article-title":"Targeted endocytosis: Strategies in drug delivery systems for enhancing antitumor efficacy","author":"Peng","year":"2025","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.04.005_bib92","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/ijbs.79328","article-title":"Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy","volume":"19","author":"Qiu","year":"2023","journal-title":"International Journal of Biological Sciences"},{"issue":"4","key":"10.1016\/bs.apcsb.2026.04.005_bib93","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/cancers13040670","article-title":"Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting","volume":"13","author":"Rahim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib94","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jconrel.2022.11.009","article-title":"Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer","volume":"352","author":"Rajana","year":"2022","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"21","key":"10.1016\/bs.apcsb.2026.04.005_bib95","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1039\/D2NA00485B","article-title":"Transformable nanoparticles to bypass biological barriers in cancer treatment","volume":"4","author":"Ramachandran","year":"2022","journal-title":"Nanoscale Advances"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114926","article-title":"Optimization of a detergent-based protocol for membrane proteins purification from mammalian cells","volume":"219","author":"Rampado","year":"2022","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.04.005_bib97","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1208\/s12249-024-02843-5","article-title":"Stealth nanocarriers in cancer therapy: A comprehensive review of design, functionality, and clinical applications","volume":"25","author":"Saadh","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/bs.apcsb.2026.04.005_bib98","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ipha.2024.03.001","article-title":"Computational transformation in drug discovery: A comprehensive study on molecular docking and quantitative structure activity relationship (QSAR)","volume":"2","author":"Shah","year":"2024","journal-title":"Intelligent Pharmacy"},{"issue":"5","key":"10.1016\/bs.apcsb.2026.04.005_bib99","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1021\/acs.chemrev.3c00778","article-title":"Theranostic fluorescent probes","volume":"124","author":"Sharma","year":"2024","journal-title":"Chemical Reviews"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib100","first-page":"1213","volume":"17","author":"Shekhar","year":"2022"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib101","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12951-023-01826-1","article-title":"Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics","volume":"21","author":"Shi","year":"2023","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301726","article-title":"Tailored drug delivery platforms: Stimulus\u2010responsive core\u2013shell structured nanocarriers","volume":"13","author":"Shi","year":"2024","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib103","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002355","article-title":"Next-generation nanocarriers for precision antitumor therapy: From passive targeting to intelligent response","volume":"6","author":"Singh","year":"2025","journal-title":"Exploration of Targeted Anti-Tumor Therapy"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.nxnano.2025.100336","article-title":"Innovations in targeted drug delivery: From nanotechnology to clinical applications","volume":"9","author":"Srivastava","year":"2026","journal-title":"Next Nanotechnology"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib105","series-title":"Artificial intelligence, big data, blockchain and 5G for the digital transformation of the healthcare industry","first-page":"365","article-title":"Digital twins in healthcare and biomedicine","author":"Subasi","year":"2024"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib106","series-title":"Polymeric nanoparticles for the treatment of solid tumors","first-page":"373","article-title":"Polymer-based nanoplatforms for targeting breast cancer","author":"Tade","year":"2022"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s44301-025-00014-4","article-title":"Beyond PEGylation: Nanoparticle surface modulation for enhanced cancer therapy","volume":"1","author":"Taghavimandi","year":"2025","journal-title":"Health Nanotechnology"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1688057","article-title":"Antibody\u2013drug conjugate: A newly developed biological missile for tumor treatment","volume":"15","author":"Tang","year":"2025","journal-title":"Frontiers in Oncology"},{"issue":"9","key":"10.1016\/bs.apcsb.2026.04.005_bib109","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/pharmaceutics17091106","article-title":"Aptamer-nanoconjugates as potential theranostics in major neuro-oncological and neurodegenerative disorders","volume":"17","author":"Tauser","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib110","first-page":"1399","article-title":"Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges","author":"Toporkiewicz","year":"2015","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.crimmu.2023.100073","article-title":"Nanoparticles cellular uptake, trafficking, activation, toxicity and in vitro evaluation","volume":"4","author":"Toscano","year":"2023","journal-title":"Current Research in Immunology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib112","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s11671-023-03943-0","article-title":"Exploration of inorganic nanoparticles for revolutionary drug delivery applications: A critical review","volume":"18","author":"Unnikrishnan","year":"2023","journal-title":"Discover Nano"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400023","article-title":"Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?","volume":"47","author":"Van Acker","year":"2025","journal-title":"Bioessays: News and Reviews in Molecular, Cellular and Developmental Biology"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib114","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-12-824476-0.00012-7","article-title":"Folate receptor-mediated targeted breast cancer nanomedicine","author":"Varan","year":"2022","journal-title":"Targeted Nanomedicine for Breast Cancer Therapy"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.04.005_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid lipid nanoparticles vs. Nanostructured lipid carriers: A comparative review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib116","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12951-022-01605-4","article-title":"Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery","volume":"20","author":"Waheed","year":"2022","journal-title":"Journal of Nanobiotechnology"},{"issue":"23","key":"10.1016\/bs.apcsb.2026.04.005_bib117","doi-asserted-by":"crossref","first-page":"24759","DOI":"10.1021\/acs.jmedchem.5c01861","article-title":"Small molecule-drug conjugates: An emerging drug design strategy for targeted therapeutics","volume":"68","author":"Wang","year":"2025","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib118","article-title":"Understanding of endo\/lysosomal escape of nanomaterials in biomedical application","author":"Wang","year":"2025","journal-title":"Smart Molecules"},{"issue":"null","key":"10.1016\/bs.apcsb.2026.04.005_bib119","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.2147\/IJN.S459710","article-title":"Smart nanoplatforms responding to the tumor microenvironment for precise drug delivery in cancer therapy","volume":"19","author":"Wang","year":"2024","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib120","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2147\/OTT.S550104","article-title":"Precision nanomedicine for cancer: Innovations, strategies, and translational challenges","volume":"18","author":"Wen","year":"2025","journal-title":"OncoTargets and Therapy"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib121","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fbioe.2022.1024143","article-title":"Polymeric nanoparticles\u2014Promising carriers for cancer therapy [Review]","volume":"10","author":"Xiao","year":"2022","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"9","key":"10.1016\/bs.apcsb.2026.04.005_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70337","article-title":"Nanocarrier\u2010based systems for targeted delivery: Current challenges and future directions","volume":"6","author":"Xu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib123","series-title":"Advancements in nanobiology","first-page":"176","article-title":"Nanobiology of infectious diseases","author":"Yadav","year":"2025"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib124","article-title":"The heating efficiency of magnetic nanoparticles under an alternating magnetic field","volume":"12","author":"Yu","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2022.09.029","article-title":"Reshaping hypoxia and silencing CD73 via biomimetic gelatin nanotherapeutics to boost immunotherapy","volume":"351","author":"Yuan","year":"2022","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"issue":"7","key":"10.1016\/bs.apcsb.2026.04.005_bib126","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/polym15071596","article-title":"Nanoparticles as drug delivery systems: A review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems","volume":"15","author":"Yusuf","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125902","article-title":"Aptamer-drug conjugates (ApDCs): Transformative approaches in targeted cancer therapy and precision oncology","author":"Zahedi","year":"2025","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib128","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib129","article-title":"Moving beyond traditional therapies: The role of nanomedicines in lung cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib130","article-title":"Breaking glycolysis barriers to immunotherapy with nanomedicines","author":"Zhang","year":"2025","journal-title":"ACS Nano Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.04.005_bib131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12964-025-02308-7","article-title":"Mitochondrial dysfunction in the regulation of aging and aging-related diseases","volume":"23","author":"Zhang","year":"2025","journal-title":"Cell Communication and Signaling"},{"key":"10.1016\/bs.apcsb.2026.04.005_bib132","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.2147\/IJN.S538382","article-title":"Liposome-based nanoparticle delivery systems for lung diseases: Opportunities and challenges","author":"Zhang","year":"2025","journal-title":"International Journal of Nanomedicine"},{"issue":"21","key":"10.1016\/bs.apcsb.2026.04.005_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202504672","article-title":"Precision\u2010guided stealth missiles in biomedicine: Biological carrier\u2010mediated nanomedicine hitchhiking strategy","volume":"12","author":"Zhou","year":"2025","journal-title":"Advanced Science"},{"issue":"4","key":"10.1016\/bs.apcsb.2026.04.005_bib134","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0958-1669(98)80017-7","article-title":"Phage-displayed peptide libraries","volume":"9","author":"Zwick","year":"1998","journal-title":"Current Opinion in Biotechnology"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Molecular targets and therapeutic design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162326000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162326000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:36:23Z","timestamp":1784043383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162326000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345234"],"references-count":134,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2026.04.005","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}